Interleukin Genetics Inc (ILIU) - Financial and Strategic SWOT Analysis Review

May 2017 | 53 pages | ID: IEAFE0A0074EN
GlobalData

Abstracts

Interleukin Genetics Inc (ILIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include PerioPredict genetic risk test; Weight management genetic test; Bone health genetic test; Heart health genetic test; Nutritional needs genetic test; and Wellness select genetic test. PerioPredict genetic test analyzes genetic variations that are associated with inflammation and helps in identifying individuals who are at increased risk for severe periodontal disease. Its genetic test product pipeline includes IL-1 genetic test for cardiovascular disease and osteoarthritis genetic test for osteoarthritis (OA). The company distributes its products through partnership with healthcare professionals, health and wellness companies, and distribution channels. Interleukin is headquartered in Waltham, Massachusetts, the US.

Interleukin Genetics Inc Key Recent Developments

May 12,2017: Interleukin Genetics Reports First Quarter 2017 Financial Results
Apr 18,2017: Interleukin Genetics Reports Fourth Quarter and Year-End 2016 Financial Results
Feb 23,2017: Interleukin Genetics Deploys ILUSTRA Inflammation Management Program with mPulse Mobile Employees
Feb 15,2017: IG and PBGH Forge Relationship To Bring ILUSTRATM To Pittsburgh Employers
Nov 15,2016: Interleukin Genetics Reports Third Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Interleukin Genetics Inc - Key Facts
Interleukin Genetics Inc - Key Employees
Interleukin Genetics Inc - Key Employee Biographies
Interleukin Genetics Inc - Major Products and Services
Interleukin Genetics Inc - Medical Equipment Pipeline Products Data
Interleukin Genetics Inc Pipeline Products by Equipment Type
Interleukin Genetics Inc Pipeline Products by Development Stage
Interleukin Genetics Inc - History
Interleukin Genetics Inc - Company Statement
Interleukin Genetics Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Interleukin Genetics Inc - Business Description
Interleukin Genetics Inc - Corporate Strategy
Interleukin Genetics Inc - SWOT Analysis
SWOT Analysis - Overview
Interleukin Genetics Inc - Strengths
Interleukin Genetics Inc - Weaknesses
Interleukin Genetics Inc - Opportunities
Interleukin Genetics Inc - Threats
Interleukin Genetics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Interleukin Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Interleukin Genetics Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017
Interleukin Genetics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 12, 2017: Interleukin Genetics Reports First Quarter 2017 Financial Results
Apr 18, 2017: Interleukin Genetics Reports Fourth Quarter and Year-End 2016 Financial Results
Feb 23, 2017: Interleukin Genetics Deploys ILUSTRA Inflammation Management Program with mPulse Mobile Employees
Nov 15, 2016: Interleukin Genetics Reports Third Quarter 2016 Financial Results
Nov 03, 2016: Interleukin Genetics Launches The ILUSTRA Inflammation Management Program
Aug 16, 2016: Interleukin Genetics Reports Second Quarter 2016 Financial Results
Aug 03, 2016: Interleukin Genetics Strengthens Commercial Leadership with Key Appointments
May 16, 2016: Interleukin Genetics Reports First Quarter 2016 Financial Results
Mar 17, 2016: Interleukin Genetics Reports Fourth Quarter and Year-End 2015 Financial Results
Mar 16, 2016: Interleukin Genetics Appoints Global Clinical Advisory Board To Guide Enhanced Healthcare through Targeted Management of Systemic Inflammation

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Interleukin Genetics Inc, Key Facts
Interleukin Genetics Inc, Key Employees
Interleukin Genetics Inc, Key Employee Biographies
Interleukin Genetics Inc, Major Products and Services
Interleukin Genetics Inc Pipeline Products by Equipment Type
Interleukin Genetics Inc Number of Pipeline Products by Development Stage
Interleukin Genetics Inc Pipeline Products Summary by Development Stage
Interleukin Genetics Inc, History
Interleukin Genetics Inc, Key Competitors
Interleukin Genetics Inc, Ratios based on current share price
Interleukin Genetics Inc, Annual Ratios
Interleukin Genetics Inc, Annual Ratios (Cont.1)
Interleukin Genetics Inc, Interim Ratios
Interleukin Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Interleukin Genetics Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017
Interleukin Genetics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Interleukin Genetics Inc Pipeline Products by Equipment Type
Interleukin Genetics Inc Pipeline Products by Development Stage
Interleukin Genetics Inc, Performance Chart (2012 - 2016)
Interleukin Genetics Inc, Ratio Charts
Interleukin Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Interleukin Genetics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

The Nature’s Bounty Co
Satoris, Inc.
Myriad Genetics Inc
Good Start Genetics Inc
Clarient Inc